Aller directement au contenu
Cellules endothéliales de la veine saphène humaine (HSVEC)
Tissu
Saphenous vein
Maladie
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Site métastatique
Not applicable (normal, non-tumorigenic primary cell)
Synonymes
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Documents

Cellules endothéliales de la veine saphène humaine (HSVEC)

Primary cell · Référence du produit 300699

Venous endothelium for bypass graft research

€1,220.00hors taxes et frais de port

Personnalisation / Recommandations

Fabriqué sur commande
1

01Informations générales

Description

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Tissu
Saphenous vein
Maladie
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Site métastatique
Not applicable (normal, non-tumorigenic primary cell)
Applications
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Synonymes
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Donateur

Âge du donneur
Lot-specific (see CoA)
Origine ethnique
Lot-specific (see CoA)

03Classification

Organisme
Humain
Sexe
Spécifique au lot
Propriétés de croissance
Adepte
Statut OGM
Sans OGM
Informations détaillées sur le statut OGM
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Niveau de biosécurité
1

04Caractéristiques

Morphologie
Cobblestone (endothelial)
Type de cellule
Primary endothelial cells
Tumorigène
No
Temps de doublement
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Manipulation et culture

Milieu de culture
Endothelial Cell Growth Medium
Atmosphère d'incubation

37°C, 5% CO2, saturated humidity.

Compléments alimentaires
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Réactif de dissociation
Subculture reagents as recommended on the certificate of analysis
Revêtement de flacons
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Repiquage

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Rapport de fractionnement
1 to 3
Densité de semis
More than 6,000 cells/cm²
Renouvellement des fluides
24 hours after seeding, then every 48 to 72 hours
Récupération après le dégel

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Décongélation et mise en culture
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Contrôle qualité et cryoconservation

Stérilité

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Milieu de congélation
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Conditions de stockage

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Conditions de livraison

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expression et sensibilité

Antigènes de surface
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Récepteurs exprimés
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identifiants

Référence
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
Numéro d'identification fiscale NCBI
9606
Cellosaurus
Not assigned